Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles
The healthy microbiome protects against the development of Clostridium difficile infection (CDI) which typically develops following antibiotics. The microbiome metabolises primary to secondary bile acids, a process if disrupted by antibiotics, may be critical for the initiation of CDI.
Alimentary pharmacology therapeutics